-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Kotak Alternate Asset Managers has announced a Rs 1,445 crore investment in the acquisition of Viatris' active pharmaceutical ingredient...
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2025
(366)
-
▼
May
(55)
- Sun Pharma lines up USD 100 mn to commercialise ni...
- US FDA approves Moderna's next-gen COVID vaccine f...
- Big fat legal war bursts out ahead of Novo Nordisk...
- Daiichi comments continue to damage interests: IHH...
- Fortis Open Offer: Daiichi Sankyo's 'misleading' s...
- Flush expired, unused opioids down the toilet, say...
- India gears up to reboot ICU standards, fix doctor...
- Novartis offers payment plan for high-cost heart m...
- Quadria's third fund nets $1 billion, to deploy 60...
- Lupin inks licensing deal to supply biosimilar ran...
- VC funding, influencers power India’s health suppl...
- Dr Reddy's gets 2 observations from USFDA for Tela...
- China’s India Headache: The growing pharmaceutical...
- Venus Remedies gets Ukrainian GMP renewal certific...
- Waive risk-based inspections, urges MSME pharma body
- Sun Pharma to invest $25 mn in Pharmazz Inc; raise...
- Alembic Pharma gets USFDA nod for generic high blo...
- Zydus working on single pen device for adjustable ...
- Many MSME pharma firms making substandard drugs, C...
- Neuberg, Star Imaging in joint venture to expand i...
- Bharat Biotech's cholera vaccine successfully comp...
- Aman Mehta appointed Managing Director of Torrent ...
- IHH Healthcare increases damages claim against Dai...
- Domestic drug companies in a sweet spot as global ...
- India's orthopaedic and cardiac implant sector to ...
- Non-AI organisations won't make it to 2050, says D...
- Dr Reddy's gets 2 observations from USFDA for New ...
- 'Irrational' fixed dose combos harmful, may face b...
- Piramal Pharma to stay away from prescription busi...
- Generic pharma companies unlikely to be impacted b...
- Biocon plans ₹4,500-cr QIP to raise stake in Biolo...
- Revolutionary Non-Surgical Hair Growth Treatment b...
- Donald Trump’s order to lower prices may benefit g...
- US govt order to have nil impact on Indian pharma ...
- Lupin launches generic version of kidney disorder ...
- Trump drops the price bomb, Indian pharma may feel...
- India has not accepted 'data exclusivity' demand b...
- Trump's drug order sparks concern for India's phar...
- Biocon plans $150-million capex in two years
- Dr. Reddy's eyes aspirational goal to be in top fi...
- FDC recalls over 60,000 bottles of ophthalmic solu...
- Zydus gets USFDA nod for generic drug to treat mul...
- Generic versions of key diabetic drug in market do...
- Mounjaro is now a heavyweight in weight-loss fight
- Aster DM Healthcare to invest Rs 480 cr to set up ...
- Trump's new executive orders may hit Indian Pharma...
- Trump's prescription: Indian drug units may face s...
- TPG to acquire 35% stake in SCHOTT Poonawalla from...
- Revised rules for biosimilar drugs enter the final...
- Biocon Biologics secures multiple market access ag...
- Manipal, IHH, EQT & others eye Sahyadri Hospitals ...
- Panel to take a call on doorstep medicine delivery
- With weight-loss drugs, going under the knife may ...
- Alembic gets USFDA nod for generic drug
- Opioid Tapentadol may be put under Narcotics Act t...
-
▼
May
(55)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment